Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 11, 2009, Pages 2814-2821

  Ahn, Jiyoung ^a   Lim, Unhee ^a   Weinstein, Stephanie J ^a   Schatzkin, Arthur ^a   Hayes, Richard B ^a   Virtamo, Jarmo ^b   Albanes, Demetrius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLADDER CANCER; BRAIN CANCER; CANCER INCIDENCE; CANCER RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COLORECTAL CANCER; ESOPHAGUS CANCER; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RISK REDUCTION; STOMACH CANCER;

CHOLESTEROL; CHOLESTEROL, HDL; COHORT STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 72749091502     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1248     Document Type: Article

References (38)

1. Rose G, Blackburn H, Keys A, Taylor HL, Kannel WB, Paul O, et al. Colon cancer and blood-cholesterol. Lancet 1974;1:181-183
2. Rose G, Shipley MJ. Plasma lipids and mortality: a source of error. Lancet 1980;1:523-526 (Pubitemid 10176630)
3. Cambien F, Ducimetiere P,Richard J. Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol 1980; 112:388-394 (Pubitemid 10019229)
4. Beaglehole R, Foulkes MA, Prior IA, Eyles EF. Cholesterol and mortality in New Zealand Maoris. Br Med J 1980;280:285-287 (Pubitemid 10213082)
5. Kagan A, McGee DL, Yano K, Rhoads GG, Nomura A. Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart program. Am J Epidemiol 1981;114:11-20. (Pubitemid 11048265)
6. Garcia-Palmieri MR, Sorlie PD, Costas R, Jr., Havlik RJ. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol 1981;114:29-40. (Pubitemid 11048267)
7. Peterson B, Trell E. Premature mortality in middle-aged men: serum cholesterol as risk factor. Wien Klin Wochenschr 1983;61:795-801.
8. Sorlie PD, Fienleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J Natl Cancer Inst 1982;69:989-996
9. International Collaborative Group. Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years. JAMA 1982; 248:2853-2859
10. Morris DL, Borhani NO, Fitzsimons E, Hardy RJ, Hawkins CM, Kraus JF, et al. Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program. Cancer 1983;52:1754-1759
11. Sherwin RW,Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 1987; 257:943-948 (Pubitemid 17024387)
12. Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. Cancer incidence by levels of cholesterol. JAMA 1981; 245:247-252
13. Kark JD, Smith AH, Hames CG. The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chronic Dis 1980;33:311-332
14. Wallace RB, Rost C, Burmeister LF, Pomrehn PR. Cancer incidence in humans: relationship to plasma lipids and relative weight. J Natl Cancer Inst 1982;68:915-918 (Pubitemid 12040914)
15. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, et al. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-1060
16. Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Larson DB, et al. Serum cholesterol and cancer in the NHANES I epidemiologic follow-up study. National Health and Nutrition Examination Survey. Lancet 1987;2:298-301. (Pubitemid 17104205)
17. Kritchevsky SB, Wilcosky TC, Morris DL, Truong KN, Tyroler HA. Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res 1991;51: 3198-3203.
18. Nofer JR, Junker R, Pulawski E, Fobker M, Levkau B, von Eckardstein A, et al. High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway. Thromb Haemost 2001;85:730-735 (Pubitemid 32293712)
19. Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, von Eckardstein A, et al. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 2001;276:34480-34485 (Pubitemid 37384437)
20. Lim U, Gayles T, Katki HA, Stolzenberg-Solomon R, Weinstein SJ, Pietinen P, et al. Serum high-density lipoprotein cholesterol and risk of non-Hodgkin lymphoma. Cancer Res 2007;67:5569-5574 (Pubitemid 46997300)
21. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004;96:1152-1160 (Pubitemid 39207051)
22. Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, et al. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev 1998;7:483-488 (Pubitemid 28354111)
23. Kucharska-Newton AM, Rosamond WD, Schroeder JC, McNeill AM, Coresh J, Folsom AR. HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study. Lung Cancer 2008;61:292-300.
24. The ATBC Cancer Prevention Study Group. The α-tocopherol, β-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. Ann Epidemiol 1994;4:1-10.
25. Korhonen P,Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort - accuracy and delay. Acta Oncol 2002;41:381-388 (Pubitemid 34941123)
26. Pietinen P,Hartman AM, Haapa E, Rasanen L, Haapakoski J, Palmgren J, et al. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988;128:655-666
27. Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP.Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke 1999;30:2535-2540
28. Paunio M, Heinonen OP, Virtamo J, Klag MJ, Manninen V, Albanes D, et al. HDL cholesterol and mortality in Finnish men with special reference to alcohol intake. Circulation 1994;90:2909-2918
29. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-561 (Pubitemid 19116001)
30. Jacobs DR, Jr., Hebert B, Schreiner PJ, Sidney S, Iribarren C, Hulley S. Reduced cholesterol is associated with recent minor illness: the CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol 1997;146:558-564
31. Mainous AG III, Wells BJ, Koopman RJ, Everett CJ, Gill JM. Iron, lipids, and risk of cancer in the Framingham Offspring cohort. Am J Epidemiol 2005;161:1115-1122
32. von Eckardstein A, Hersberger M, Rohrer L. Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care 2005;8:147-152 (Pubitemid 40289474)
33. Siemianowicz K, Gminski J, Stajszczyk M, Wojakowski W, Goss M, Machalski M, et al. Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer. Int J Mol Med 2000;6: 307-311
34. Umeki S. Decreases in serum cholesterol levels in advanced lung cancer. Respiration 1993;60:178-181 (Pubitemid 23250149)
35. Dessi S, Batetta B, Pulisci D, Spano O, Cherchi R, Lanfranco G, et al. Altered pattern of lipid metabolism in patients with lung cancer. Oncology 1992;49:436-441
36. Jiang J, Nilsson-Ehle P, Xu N. Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis 2006;5:4.
37. Jiang JT, Xu N, Wu CP. Metabolism of high density lipoproteins in liver cancer. World J Gastroenterol 2007;13:3159-3163 (Pubitemid 47064576)
38. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421